195 related articles for article (PubMed ID: 22073263)
1. Molecular evolution of HIV-1 CRF01_AE Env in Thai patients.
Boonchawalit S; Jullaksorn D; Uttiyoung J; Yowang A; Krathong N; Chautrakul S; Yamashita A; Ikuta K; Roobsoong A; Kanitvittaya S; Sawanpanyalert P; Kameoka M
PLoS One; 2011; 6(11):e27098. PubMed ID: 22073263
[TBL] [Abstract][Full Text] [Related]
2. Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site.
Utachee P; Isarangkura-na-ayuthaya P; Tokunaga K; Ikuta K; Takeda N; Kameoka M
Retrovirology; 2014 Apr; 11():32. PubMed ID: 24758333
[TBL] [Abstract][Full Text] [Related]
3. Two N-linked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domain.
Utachee P; Nakamura S; Isarangkura-Na-Ayuthaya P; Tokunaga K; Sawanpanyalert P; Ikuta K; Auwanit W; Kameoka M
J Virol; 2010 May; 84(9):4311-20. PubMed ID: 20164234
[TBL] [Abstract][Full Text] [Related]
4. [Study on the evolutionary pressure on the env gene of the human immunodeficiency virus type 1 CRF01-AE strains circulating in China].
Liang H; Xing H; Wei M; Chen Z; Guan Q; Huang HL; Quan Y; Chen JP; Hong KX; Shi LY; Shao YM
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):966-70. PubMed ID: 14687493
[TBL] [Abstract][Full Text] [Related]
5. A 2-4-Amino Acid Deletion in the V5 Region of HIV-1 Env gp120 Confers Viral Resistance to the Broadly Neutralizing Human Monoclonal Antibody, VRC01.
Tachibana S; Sasaki M; Tanaka T; Inoue M; Ophinni Y; Kotaki T; Kameoka M
AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1248-1257. PubMed ID: 28903577
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic studies on recombinant human immunodeficiency virus type 1 (HIV-1) containing CRF01_AE env gene derived from HIV-1-infected patient, residing in central Thailand.
Utachee P; Jinnopat P; Isarangkura-Na-Ayuthaya P; de Silva UC; Nakamura S; Siripanyaphinyo U; Wichukchinda N; Tokunaga K; Yasunaga T; Sawanpanyalert P; Ikuta K; Auwanit W; Kameoka M
Microbes Infect; 2009 Mar; 11(3):334-43. PubMed ID: 19136072
[TBL] [Abstract][Full Text] [Related]
7. Genotypic characterization of CRF01_AE env genes derived from human immunodeficiency virus type 1-infected patients residing in central Thailand.
Utachee P; Jinnopat P; Isarangkura-Na-Ayuthaya P; de Silva UC; Nakamura S; Siripanyaphinyo U; Wichukchinda N; Tokunaga K; Yasunaga T; Sawanpanyalert P; Ikuta K; Auwanit W; Kameoka M
AIDS Res Hum Retroviruses; 2009 Feb; 25(2):229-36. PubMed ID: 19108694
[TBL] [Abstract][Full Text] [Related]
8. [Distribution of recombinant human immunodeficiency virus type-1 CRF01_AE strains in China and its sequence variations in the env V3-C3 region].
Xing H; Liang H; Wan ZY; Chen X; Wei M; Ma PF; Guan Q; Quan Y; Hong KX; Shao YM
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):300-4. PubMed ID: 15498240
[TBL] [Abstract][Full Text] [Related]
9. Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins.
Zoubchenok D; Veillette M; Prévost J; Sanders-Buell E; Wagh K; Korber B; Chenine AL; Finzi A
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928014
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human immunodeficiency virus type 1 CRF01_AE env genes derived from recently infected Thai individuals.
Chaitaveep N; Utachee P; Nakamura S; Chuenchitra T; Ekpo P; Takeda N; Pattanapanyasat K; Kameoka M
Microbes Infect; 2014 Feb; 16(2):142-52. PubMed ID: 24513704
[TBL] [Abstract][Full Text] [Related]
11. Critical amino acid residues and potential N-linked glycosylation sites contribute to circulating recombinant form 01_AE pathogenesis in Northeast China.
Li QH; Shao B; Li J; Wang JY; Song B; Lin YL; Huo QQ; Liu SY; Wang FX; Liu SL
AIDS; 2019 Jul; 33(9):1431-1439. PubMed ID: 30889014
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
Keller PW; Morrison O; Vassell R; Weiss CD
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
[TBL] [Abstract][Full Text] [Related]
13. [Identification of signature amino acids in the env V3-V4 and flanking regions of human immunodeficiency virus type 1 predominant strains in China].
Liang H; Xing H; Li JZ; Wei M; Hong KX; Feng Y; Zhao QB; Chen JP; Quan Y; Teng T; Shao YM
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):897-902. PubMed ID: 16029528
[TBL] [Abstract][Full Text] [Related]
14. Common antibody dependent cell mediated cytotoxicity (ADCC) antibody epitopes of HIV-1 CRF01_AE Env and Gag in early HIV-1 infected individuals.
Sangjan S; Ampol S; Tabprasit S; Horthongkham N; Chuenchitra T; Ekpo P; Kantakamalakul W
Asian Pac J Allergy Immunol; 2019 Mar; 37(1):43-50. PubMed ID: 29602284
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.
Gao F; Morrison SG; Robertson DL; Thornton CL; Craig S; Karlsson G; Sodroski J; Morgado M; Galvao-Castro B; von Briesen H; Beddows S; Weber J; Sharp PM; Shaw GM; Hahn BH
J Virol; 1996 Mar; 70(3):1651-67. PubMed ID: 8627686
[TBL] [Abstract][Full Text] [Related]
16. [Sequence analysis of the full-length glycoprotein 120 gene of HIV-1 CRF01_AE in Fujian, China].
Huang HL; Zheng J; Yan PP; Wu SL; Chen G; Lin X; Zheng WX; Xie MR; Zhang JM; Yan YS
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3104-8. PubMed ID: 17313760
[TBL] [Abstract][Full Text] [Related]
17. Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants.
Wang B; Lau KA; Ong LY; Shah M; Steain MC; Foley B; Dwyer DE; Chew CB; Kamarulzaman A; Ng KP; Saksena NK
Virology; 2007 Oct; 367(2):288-97. PubMed ID: 17604072
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.
Wen Y; Trinh HV; Linton CE; Tani C; Norais N; Martinez-Guzman D; Ramesh P; Sun Y; Situ F; Karaca-Griffin S; Hamlin C; Onkar S; Tian S; Hilt S; Malyala P; Lodaya R; Li N; Otten G; Palladino G; Friedrich K; Aggarwal Y; LaBranche C; Duffy R; Shen X; Tomaras GD; Montefiori DC; Fulp W; Gottardo R; Burke B; Ulmer JB; Zolla-Pazner S; Liao HX; Haynes BF; Michael NL; Kim JH; Rao M; O'Connell RJ; Carfi A; Barnett SW
PLoS One; 2018; 13(4):e0194266. PubMed ID: 29698406
[TBL] [Abstract][Full Text] [Related]
19. The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.
Borrego P; Marcelino JM; Rocha C; Doroana M; Antunes F; Maltez F; Gomes P; Novo C; Barroso H; Taveira N
Retrovirology; 2008 Sep; 5():78. PubMed ID: 18778482
[TBL] [Abstract][Full Text] [Related]
20. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC
J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
